Related Experiment Video
Updated: May 21, 2026

07:32
Interlinked Macroporous 3D Scaffolds from Microgel Rods
Published on: June 16, 2022
Porous polysaccharide-based scaffolds for human endothelial progenitor cells
Mélanie Lavergne1, Mohammed Derkaoui, Catherine Delmau
1Inserm, U972, Hôpital Paul Brousse, Villejuif, France.
Macromolecular Bioscience
|June 15, 2012
Summary
Human endothelial colony-forming cells (ECFCs) are vital for vascular repair and treating ischemic diseases. Researchers developed natural polysaccharide scaffolds that support ECFC viability, proliferation, and function for potential cell therapies.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Vascular Biology
Background:
- Human endothelial colony-forming cells (ECFCs) are crucial for vascular repair and hold potential for treating ischemic diseases.
- Developing effective cell delivery systems is essential for harnessing the therapeutic capabilities of ECFCs.
Purpose of the Study:
- To create and characterize novel porous scaffolds from natural polysaccharides (pullulan and dextran) for ECFC culture.
- To evaluate the biocompatibility and functional support of these scaffolds for ECFCs.
- To assess the potential of these scaffolds for cell delivery in vascular disease treatment.
Main Methods:
- Fabrication of porous scaffolds using chemical crosslinking of pullulan and dextran without organic solvents.
- Characterization of scaffold properties, including pore size (average 42 µm) and porosity (21%).
- In vitro culture of human cord-blood ECFCs on the scaffolds, followed by assessment of cell viability, proliferation, endothelial marker expression (CD31, vWf), and endothelial functions.
Main Results:
- The pullulan-dextran scaffolds successfully preserved ECFC viability and proliferation.
- Cultured ECFCs expressed key endothelial markers (CD31, vWf) and maintained endothelial functions after 7 days.
- ECFCs could be easily retrieved from the scaffolds via enzymatic degradation.
Conclusions:
- The developed natural polysaccharide porous scaffolds provide a biocompatible and supportive environment for ECFCs.
- These scaffolds demonstrate potential as a cell delivery system for ECFC-based therapies in vascular diseases.
- Further in vitro and in vivo studies are warranted to validate their therapeutic efficacy.

